Substance / Medication

Delavirdine

Overview

Active Ingredient
delavirdine
RxNorm CUI
83816

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:
Population pharmacokinetics of delavirdine and N-delavirdine in HIV-infected individuals.
Smith Patrick F, Dicenzo Robert, Forrest Alan et al. · Clin Pharmacokinet · 2005
PMID: 15634033Trial
Dose-dependent pharmacokinetics of delavirdine in combination with amprenavir in healthy volunteers.
Justesen Ulrik S, Klitgaard Niels A, Brosen Kim et al. · J Antimicrob Chemother · 2004
PMID: 15150174Trial
Pharmacokinetic interaction between amprenavir and delavirdine after multiple-dose administration in healthy volunteers.
Justesen Ulrik S, Klitgaard Niels A, Brosen Kim et al. · Br J Clin Pharmacol · 2003
PMID: 12534646TrialFull text (PMC)
Delavirdine malabsorption in HIV-infected subjects with spontaneous gastric hypoacidity.
Shelton Mark J, Hewitt Ross G, Adams John M et al. · J Clin Pharmacol · 2003
PMID: 12616670Trial
Pharmacokinetic interaction between amprenavir and delavirdine: evidence of induced clearance by amprenavir.
Tran Jonathan Q, Petersen Carolyn, Garrett May et al. · Clin Pharmacol Ther · 2002
PMID: 12496743Trial

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Delavirdine (substance)
SNOMED CT
108710001
UMLS CUI
C0288165
RxNorm CUI
83816

Clinical Data

This intervention maps to 2 entities in the Ltrl knowledge graph.

2
Conditions
0
Biomarkers
0
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.